Hypertension is a complex disease. How it is treated shouldn’t be.

To help patients with hypertension, Ardian has developed the Symplicity® Catheter System™.

Hyperactivation of the sympathetic nervous system, especially the renal sympathetic nerves, is a major contributor to the pathophysiology of hypertension. The Symplicity Catheter System uses controlled, low-power radiofrequency (RF) energy to deactivate the renal nerves, thereby selectively reducing both the pathologic central sympathetic drive to the kidney and the renal contribution to central sympathetic hyperactivity. The outcome, we hope, will be a significant and sustained reduction in both blood pressure and the level of systemically damaging neurohormones.

Since the endovascular procedure does not involve an implant, patients recover quickly and can soon return to their daily living. The device may usher in a new era in the treatment of hypertension, hopefully allowing a one-time procedure to offer patients a long-lasting benefit.